Jia Chai

440 total citations
32 papers, 217 citations indexed

About

Jia Chai is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jia Chai has authored 32 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jia Chai's work include Epigenetics and DNA Methylation (7 papers), Cancer Cells and Metastasis (5 papers) and Ubiquitin and proteasome pathways (4 papers). Jia Chai is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Cancer Cells and Metastasis (5 papers) and Ubiquitin and proteasome pathways (4 papers). Jia Chai collaborates with scholars based in China, United Kingdom and United States. Jia Chai's co-authors include Mingyang Li, Yixiong Liu, Kaijing Wang, Jing Ma, Linni Fan, Tianqi Xu, Danhui Zhao, Shuangping Guo, Qingguo Yan and Peifeng Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Letters and Materials Letters.

In The Last Decade

Jia Chai

32 papers receiving 216 citations

Peers

Jia Chai

PRM

ONCOL

IMMUN

Haijuan Xiao China

Shuye Lin China

Ifra Mushtaq India

Zhu Wang China

Mingdian Lu China

Zhixiang Zhuang China

Yanfeng Wu China

Marina Riggio Argentina

Dongkui Xu China

Q Li China

Haijuan Xiao China

Jia Chai

137 ×1.0

91 ×1.5

40 ×0.9

PRM

52 ×1.2

ONCOL

27 ×1.1

IMMUN

Citations per year, relative to Jia Chai Jia Chai (= 1×) peers Haijuan Xiao

Countries citing papers authored by Jia Chai

Since Specialization

Citations

This map shows the geographic impact of Jia Chai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Chai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Chai more than expected).

Fields of papers citing papers by Jia Chai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Chai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Chai. The network helps show where Jia Chai may publish in the future.

Co-authorship network of co-authors of Jia Chai

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Chai. A scholar is included among the top collaborators of Jia Chai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Chai. Jia Chai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Huanhuan, Jia Chai, Tianqi Xu, et al.. (2024). STC1 promotes esophageal squamous cell carcinoma progression and is associated with poor prognosis. Pathology - Research and Practice. 265. 155744–155744. 1 indexed citations

Liu, Kai, Hongyu He, Hang Chen, et al.. (2024). OTX1 regulates tumorigenesis and metastasis in glioma. Pathology - Research and Practice. 254. 155116–155116. 2 indexed citations

Xu, Tianqi, Yixiong Liu, Zhiwei Zhao, et al.. (2023). Ferroptosis in cancer stem cells. Pathology - Research and Practice. 245. 154492–154492. 10 indexed citations

Wang, Hongjie, Xin Xiao, Yameng Sun, et al.. (2023). UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma. Pathology - Research and Practice. 247. 154574–154574. 3 indexed citations

Li, Wenqing, Jin Liu, Jia Chai, et al.. (2023). TRIM21 promotes tumor progression and cancer stemness in cervical squamous cell carcinoma. Pathology - Research and Practice. 248. 154710–154710. 3 indexed citations

Li, Lingfei, Yuxin Yin, Jinping Zhang, et al.. (2023). USP18 regulates the malignant phenotypes of glioblastoma stem cells. Pathology - Research and Practice. 247. 154572–154572. 4 indexed citations

Liu, Jian, Yixi Xu, Tianqi Xu, et al.. (2023). MUC1 promotes cancer stemness and predicts poor prognosis in osteosarcoma. Pathology - Research and Practice. 242. 154329–154329. 6 indexed citations

Yin, Yuxin, et al.. (2023). BTG2 suppresses the growth and metastasis of cervical squamous cell carcinoma. Pathology - Research and Practice. 247. 154577–154577. 7 indexed citations

Xu, Tianqi, Jin Liu, Jia Chai, et al.. (2022). ZIC5 promotes aggressiveness and cancer stemness in cervical squamous cell carcinoma. Pathology - Research and Practice. 241. 154268–154268. 6 indexed citations

10.

Wang, Kaijing, Jie Wei, Jing Ma, et al.. (2022). Phosphorylation of PBK/TOPK Tyr74 by JAK2 promotes Burkitt lymphoma tumor growth. Cancer Letters. 544. 215812–215812. 5 indexed citations

11.

Liu, Yixiong, Wei He, Yu Amanda Guo, et al.. (2022). CSNK1D is associated with stemness and invasiveness in glioblastoma. Pathology - Research and Practice. 240. 154187–154187. 7 indexed citations

12.

Zhao, Yun, Guorui Sun, Jia Chai, et al.. (2022). FBXO39 predicts poor prognosis and correlates with tumor progression in cervical squamous cell carcinoma. Pathology - Research and Practice. 238. 154090–154090. 3 indexed citations

13.

Wu, Jianfeng, Fei Yao, Yuxuan Li, et al.. (2022). The cancer-testis antigen FBXO39 predicts poor prognosis and is associated with stemness and aggressiveness in glioma. Pathology - Research and Practice. 239. 154168–154168. 3 indexed citations

14.

Ma, Jing, Kaijing Wang, Jia Chai, et al.. (2021). High RSK4 expression constitutes a predictor of poor prognosis for patients with clear cell renal carcinoma. Pathology - Research and Practice. 227. 153642–153642. 5 indexed citations

15.

Li, Peifeng, Jia Chai, Zi Chen, et al.. (2021). Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. Frontiers in Oncology. 11. 622648–622648. 12 indexed citations

16.

Wang, Kaijing, Jia Chai, Jie Wei, et al.. (2021). TOPK: A new predictor of the therapeutic response to neoadjuvant chemotherapy and prognosis in triple-negative breast cancer. Pathology - Research and Practice. 226. 153603–153603. 3 indexed citations

17.

Rohr, Joseph, Yang Liu, Mingyang Li, et al.. (2020). Progress in triple negative breast carcinoma pathophysiology: Potential therapeutic targets. Pathology - Research and Practice. 216(4). 152874–152874. 8 indexed citations

18.

Ma, Jing, Mingyang Li, Jia Chai, et al.. (2020). Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC. Diagnostic Pathology. 15(1). 28–28. 24 indexed citations

19.

Li, Peifeng, Mingyang Li, Kaijing Wang, et al.. (2019). Genetic alterations in cell cycle regulation-associated genes may promote primary progression of gastrointestinal stromal tumors. Laboratory Investigation. 100(3). 426–437. 7 indexed citations

20.

Li, Mingyang, Xiaoli Su, Yingmei Wang, et al.. (2019). Lineage-negative lymphoma with a helper innate lymphoid cell phenotype. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(2). 285–293. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact